Translational research is a key priority within the University’s Life Sciences Strategy (LSS), so we can ensure basic research outputs are transformed into clinical interventions and patient benefit.
World-leading clinical trials
Birmingham Health Partners (BHP) us made up of the University, University Hospitals Birmingham NHS Foundation Trust (UHBFT) and Birmingham Children’s Hospital (BCH). It aims to ensure patients benefit from new therapies delivered by expert clinicians working alongside world-leading clinical trials teams, building on and in partnership with an outstanding basic science portfolio.
Birmingham has an established Life Sciences Campus which brings together inter-linked translational facilities. A key example is the establishment of an £8 million laboratory complex within the new QE Hospital, designated as our Centre for Translational Inflammation Research.
A major initiative for BHP is the new Institute of Translational Medicine (ITM), a world-class clinical research facility which will translate scientific research into enhanced treatments for patients. The Institute will build on Birmingham’s excellent track record in clinical trials by increasing capacity and enabling more patients to be co-located alongside clinicians and researchers.